Back to Search Start Over

Current status of carotid bifurcation angioplasty and stenting based on a consensus of opinion leaders.

Authors :
Veith FJ
Amor M
Ohki T
Beebe HG
Bell PR
Bolia A
Bergeron P
Connors JJ 3rd
Diethrich EB
Ferguson RD
Henry M
Hobson RW 2nd
Hopkins LN
Katzen BT
Matthias K
Roubin GS
Theron J
Wholey MH
Yadav SS
Source :
Journal of vascular surgery [J Vasc Surg] 2001 Feb; Vol. 33 (2 Suppl), pp. S111-6.
Publication Year :
2001

Abstract

Objective: Carotid bifurcation angioplasty and stenting (CBAS) has generated controversy and widely divergent opinions about its current therapeutic role. To resolve differences and establish a unified view of CBAS' present role, a consensus conference of 17 experts, world opinion leaders from five countries, was held on November 21, 1999.<br />Methods: These 17 participants had previously answered 18 key questions on current CBAS issues. At the conference these 18 questions and participants' answers were discussed and in some cases modified to determine points of agreement (consensus), near consensus, (prevailing opinion), or divided opinion (disagreement).<br />Results: Conference discussion added two modified questions, placing a total of 20 key questions before the participants, representing four specialties (interventional radiology, seven; vascular surgery, six; interventional cardiology, three; neurosurgery, one). It is interesting that consensus was reached on the answers to 11 (55%) of 20 of the questions, and near consensus was reached on answers to 6 (30%) of 20 of the questions. Only with the answers to three (15%) of the questions was there persisting controversy. Moreover, both these differences and areas of agreement crossed specialty lines. Consensus Conclusions: CBAS should not currently undergo widespread practice, which should await results of randomized trials. CBAS is currently appropriate treatment for patients at high risk in experienced centers. CBAS is not generally appropriate for patients at low risk. Neurorescue skills should be available if CBAS is performed. When cerebral protection devices are available, they should be used for CBAS. Adequate stents and technology for performing CBAS currently exist. There were divergent opinions regarding the proportions of patients presently acceptable for CBAS treatment (<5% to 100%, mean 44%) and best treated by CBAS (<3% to 100%, mean 34%). These and other consensus conclusions will help physicians in all specialties deal with CBAS in a rational way rather than by being guided by unsubstantiated claims.

Details

Language :
English
ISSN :
0741-5214
Volume :
33
Issue :
2 Suppl
Database :
MEDLINE
Journal :
Journal of vascular surgery
Publication Type :
Academic Journal
Accession number :
11174821
Full Text :
https://doi.org/10.1067/mva.2001.111665